
GC68707
ATR-IN-4
Also known as (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-7-(1H-pyrazol-5-yl)imidazo[1,5-b]pyridazin-2-yl]morpholine
ATR-IN-4 is an effective ATR inhibitor· ATR-IN-4 inhibits the growth of human prostate cancer cells DU145 and human lung cancer cells NCI-H460, with IC50 values of 130·9 nM and 41·33 nM, respectively (excerpted from patent CN112142744A, compound 13)
ChemicalCAS2574545-45-0MW364.4FormulaC18H20N8O
- CAS number
- 2574545-45-0
- Molecular weight
- 364.4
- Formula
- C18H20N8O
- Solubility
- DMSO : 25 mg/mL (68·61 mM; Need ultrasonic)
- InChIKey
- BUTVLOCHWATRAS-GFCCVEGCSA-N
- Catalogue number
- GC68707
- Brand
- GLPBIO
Computed properties PubChem CID 155438987 · XLogP 0.9 · TPSA 89.2 Ų · H-bond donors 1
- XLogP
- 0.9
- TPSA
- 89.2 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 3
- Heavy atoms
- 27
SMILES C[C@@H]1COCCN1C2=NN3C(=CN=C3C4=CC=NN4)C(=C2)C5=CC=NN5C
Computed descriptors from PubChem (CID 155438987), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il